Tonghua Dongbao Pharmaceutical Co Ltd (600867) — Cash Flow-to-Debt Ratio
Tonghua Dongbao Pharmaceutical Co Ltd (600867) has a Cash Flow-to-Debt Ratio of 0.06x as of September 2025, meaning its operating cash flow of CN¥62.99 Million could theoretically repay 0% of its total liabilities (CN¥1.02 Billion) in one year. See financial agility of Tonghua Dongbao Pharmaceutical Co Ltd to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Tonghua Dongbao Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Tonghua Dongbao Pharmaceutical Co Ltd across 28 annual periods. For the full cash flow conversion analysis, see Tonghua Dongbao Pharmaceutical Co Ltd (600867) cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Tonghua Dongbao Pharmaceutical Co Ltd (1998–2025)
Year-by-year debt coverage analysis for Tonghua Dongbao Pharmaceutical Co Ltd. Check Tonghua Dongbao Pharmaceutical Co Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.86x | CN¥689.23 Million | CN¥798.84 Million | ▲ +83.6% |
| 2024 | 0.47x | CN¥459.74 Million | CN¥978.08 Million | ▼ -69.7% |
| 2023 | 1.55x | CN¥861.52 Million | CN¥555.08 Million | ▼ -63.9% |
| 2022 | 4.30x | CN¥863.09 Million | CN¥200.74 Million | ▲ +13.6% |
| 2021 | 3.78x | CN¥1.13 Billion | CN¥299.87 Million | ▼ -22.6% |
| 2020 | 4.89x | CN¥1.19 Billion | CN¥243.80 Million | ▲ +44.8% |
| 2019 | 3.38x | CN¥1.15 Billion | CN¥341.10 Million | ▲ +180.8% |
| 2018 | 1.20x | CN¥876.94 Million | CN¥729.06 Million | ▼ -73.1% |
| 2017 | 4.46x | CN¥961.19 Million | CN¥215.30 Million | ▲ +348.9% |
| 2016 | 0.99x | CN¥725.76 Million | CN¥729.76 Million | ▲ +342.0% |
| 2015 | 0.23x | CN¥294.58 Million | CN¥1.31 Billion | ▼ -13.0% |
| 2014 | 0.26x | CN¥205.89 Million | CN¥795.72 Million | ▼ -20.6% |
| 2013 | 0.33x | CN¥221.06 Million | CN¥678.23 Million | ▼ -34.8% |
| 2012 | 0.50x | CN¥194.32 Million | CN¥388.92 Million | ▲ +371.6% |
| 2011 | -0.18x | CN¥-55.07 Million | CN¥299.37 Million | ▼ -152.0% |
| 2010 | 0.35x | CN¥160.40 Million | CN¥453.75 Million | ▲ +32.9% |
| 2009 | 0.27x | CN¥166.20 Million | CN¥624.75 Million | ▲ +112.6% |
| 2008 | 0.13x | CN¥92.31 Million | CN¥737.66 Million | ▼ -23.9% |
| 2007 | 0.16x | CN¥120.94 Million | CN¥734.97 Million | ▼ -28.0% |
| 2006 | 0.23x | CN¥158.00 Million | CN¥691.13 Million | ▲ +34.9% |
| 2005 | 0.17x | CN¥92.23 Million | CN¥544.23 Million | ▲ +518.0% |
| 2004 | 0.03x | CN¥13.17 Million | CN¥480.12 Million | ▼ -76.3% |
| 2003 | 0.12x | CN¥45.51 Million | CN¥393.95 Million | ▼ -25.8% |
| 2002 | 0.16x | CN¥31.99 Million | CN¥205.52 Million | ▼ -89.7% |
| 2001 | 1.51x | CN¥117.73 Million | CN¥77.96 Million | ▲ +128.7% |
| 2000 | 0.66x | CN¥29.12 Million | CN¥44.10 Million | ▲ +164.4% |
| 1999 | -1.02x | CN¥-95.09 Million | CN¥92.79 Million | ▼ -18.0% |
| 1998 | -0.87x | CN¥-216.98 Million | CN¥249.82 Million | — |